                         SEQUENCE LISTING

<110>  ALLYSTA PHARMACEUTICALS, INC.
       Hsu, Henry
       Otvos, Laszlo
 
<120>  MONOMERIC FUSION PEPTIDES AND METHOD OF USE THEREOF

<130>  ALLY004PCT

<140>  Unknown
<141>  2022-06-02

<150>  63216688
<151>  2021-06-30

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  The C-terminal amino acid at position 30 is optionally amidated

<400>  1

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa at position 1 is D-Asn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 is Nva

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa at position 7 is D-Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa at position 10 is D-Ser-NH2

<400>  2

Xaa Ile Pro Xaa Leu Tyr Xaa Phe Ala Xaa 
1               5                   10  


<210>  3
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  The C-terminal amino acid at position 18 is optionally amidated

<400>  3

Lys Phe His Cys Asn Ile Pro Gly Leu Tyr Tyr Phe Ala Tyr His Ile 
1               5                   10                  15      


Thr Val 
        


<210>  4
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  The amino acid  Lys at position 20 is optionalyy modified at 
       epsilon amino group

<220>
<221>  MOD_RES
<222>  (28)..(28)
<223>  The amino acid  Lys at position 28 is optionalyy modified at 
       epsilon amino group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  The C-terminal amino acid at position 30 is optionally amidated

<400>  4

His Gly Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  5
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  The amino acid  Lys at position 12 is optionalyy modified at 
       epsilon amino group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  The C-terminal amino acid at position 30 is optionally amidated

<400>  5

His Gly Glu Gly Thr Phe Thr Ser Asp Val Ser Lys Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  6
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  The amino acid  Lys at position 16 is optionalyy modified at 
       epsilon amino group

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  The C-terminal amino acid at position 30 is optionally amidated

<400>  6

His Gly Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Lys 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


